According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings (TTM) are C$6.22 B. In 2023 the company made an earning of C$5.69 B a decrease over its 2022 earnings that were of C$6.59 B.The earnings displayed on this page is the company's Pretax Income.